News
-
Neumarker and UCSF Secured CIAPM Grant to Advance Precision Mental Health for At-Risk Youth
Neumarker, in collaboration with a research team from University of California, San Francisco (UCSF), has been awarded a research grant from the California Initiative to Advance Precision Medicine (CIAPM) for…
-
Neumarker to Present Innovative Machine Learning Technology at ISCTM 2024 Annual Autumn Meeting
Neumarker will present its latest research at the upcoming International Society for CNS Clinical Trials and Methodology (ISCTM) 2024 Annual Autumn Meeting, on September 12 in San Diego, CA. The…
-
Neumarker Appoints Dr. Steven Paul as Chairman of Scientific Advisory Board
Neumarker is pleased to announce the appointment of Dr. Steven M. Paul as the Chairman of its Scientific Advisory Board. Dr. Paul brings over 40 years of exceptional expertise and…
-
Neumarker Presented Groundbreaking Data Analytic Results at ASCP 2024 Annual Meeting
Dr. Qiang Li, Chief Technology Officer of Neumarker Inc., presented a talk titled “An EEG-Based, Machine Learning Biomarker to Identify Responsive vs. Non-responsive Subjects in an MDD Clinical Trial: Initial…
Neumarker 